KKR backs mon­ster $300M raise to build up a new-mod­el biotech — de­signed by Neil Ku­mar and MIT’s An­drew Lo

Neil Ku­mar al­ways want­ed to build a dif­fer­ent kind of biotech com­pa­ny at Bridge­Bio. And now the CEO has banked right un­der $300 mil­lion to con­tin­ue con­struc­tion work on the grand de­sign as he thinks about grow­ing the pipeline and start­ing their first mar­ket­ing ef­forts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER